| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/26/2002 | CA2435664A1 Ncc2705-the genome of a bifidobacterium |
| 09/26/2002 | CA2425902A1 Urocortin-iii and uses thereof |
| 09/25/2002 | EP1243660A2 Human udp-Galnac:polypeptide n-acetylgalatosaminyltransferase 10 |
| 09/25/2002 | EP1243652A2 Glial derived neurotrophic factor |
| 09/25/2002 | EP1243650A2 Process for constructing a cdna library, and a polypeptide and dna coding for the same |
| 09/25/2002 | EP1243648A1 Novel guanosine triphosphate-binding protein-coupled receptors, genes thereof and production and uses thereof |
| 09/25/2002 | EP1243597A2 Receptors for human interleukin-12 |
| 09/25/2002 | EP1243595A1 Bh4-fused polypeptides |
| 09/25/2002 | EP1243290A2 Modulation of gene expression by combination therapy |
| 09/25/2002 | EP1243289A2 Modulation of gene expression by combination therapy |
| 09/25/2002 | EP1243276A1 Elongated and multiple spacers containing activatible prodrugs |
| 09/25/2002 | EP1243275A1 Insulin-containing medicament for peroral application and method for the production thereof |
| 09/25/2002 | EP1243270A1 Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers |
| 09/25/2002 | EP1243262A1 Novel use of a peptide class of compound for treating non-neuropathic inflammatory pain |
| 09/25/2002 | EP1243252A1 Skin composition containing fibres and ubiquinones |
| 09/25/2002 | EP1243180A1 A probiotic, a food product containing a probiotic, a method for preparation of said food product, a pharmaceutical composition and a use of the probiotic strain |
| 09/25/2002 | EP1242823A2 Selecting library members capable of binding to epitopes |
| 09/25/2002 | EP1242624A2 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
| 09/25/2002 | EP1242611A2 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein |
| 09/25/2002 | EP1242609A2 Novel colloid synthetic vectors for gene therapy |
| 09/25/2002 | EP1242608A2 Method of achieving persistent transgene expression |
| 09/25/2002 | EP1242600A1 Cytokine zcyto18 |
| 09/25/2002 | EP1242598A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 09/25/2002 | EP1242596A1 Methods and materials relating to novel von willebrand/thrombospondin-like polypeptides and polynucleotides |
| 09/25/2002 | EP1242590A2 Human lyases and associated proteins |
| 09/25/2002 | EP1242588A2 Human proteins with homology to carboxypeptidases and polynucleotides encoding the same |
| 09/25/2002 | EP1242587A1 A NOVEL ISOFORM OF HUMAN cAMP-DEPENDENT PROTEIN KINASE, C ALPHA-s, LOCALIZES TO SPERM MIDPIECE AND THE USE THEREOF |
| 09/25/2002 | EP1242585A1 IDENTIFICATION OF NOVEL SPLICE VARIANTS OF THE HUMAN CATALYTIC SUBUNIT C BETA OF cAMP-DEPENDENT PROTEIN KINASE AND THE USE THEREOF |
| 09/25/2002 | EP1242584A2 Human kinases |
| 09/25/2002 | EP1242583A2 Human oxidoreductase proteins |
| 09/25/2002 | EP1242581A2 Regulation of human mitochondrial deformylase |
| 09/25/2002 | EP1242580A1 Methods and materials relating to semaphorin-like polypeptides and polynucleotides |
| 09/25/2002 | EP1242456A2 Scfv antibodies against disease associated molecules |
| 09/25/2002 | EP1242455A1 N-alkylated peptides having antiangiogenic activity |
| 09/25/2002 | EP1242453A1 Dna encoding snorf62 and snorf72 receptors |
| 09/25/2002 | EP1242452A2 Chimeric natriuretic peptides |
| 09/25/2002 | EP1242451A2 Compositions and methods for inhibiting endothelial cell proliferation |
| 09/25/2002 | EP1242447A1 Compounds and use thereof to modify transport across cell membranes |
| 09/25/2002 | EP1242435A2 Medicaments for treatment of respiratory syncytial virus infections |
| 09/25/2002 | EP1242365A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 09/25/2002 | EP1242363A2 Cd45 inhibitors |
| 09/25/2002 | EP1242122A2 Delivery of proteins across polar epithelial cell layers |
| 09/25/2002 | EP1242121A2 Polypeptide compositions with improved stability |
| 09/25/2002 | EP1242120A2 Combinations of growth factors and i:upa or i:mmp for the treatment of damaged tissue |
| 09/25/2002 | EP1242118A1 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
| 09/25/2002 | EP1242114A2 Use of enzymes for skin expansion |
| 09/25/2002 | EP1242113A2 Methods and compositions for inhibiting adhesion by microorganisms |
| 09/25/2002 | EP1242112A1 Particulate drug-containing products and method of manufacture |
| 09/25/2002 | EP1242111A1 An animal model for studying hormone signalling and method of modulating the signalling |
| 09/25/2002 | EP1242110A1 A method and composition for treating prostate cancer |
| 09/25/2002 | EP1242109A2 A method for treating viral diseases and other disorders by altering immediate gene expression through administration of peptide t |
| 09/25/2002 | EP1242107A1 Method for pr-39 peptide mediated selective inhibition of ikappabalpha degradation |
| 09/25/2002 | EP1242070A2 Treatment of ischemic brain injuries with brain targetted antioxidant compounds |
| 09/25/2002 | EP1242063A1 Compositions and methods for treatment of neurological disorders and neurodegenerative diseases |
| 09/25/2002 | EP1242060A1 Treatment of metastatic disease |
| 09/25/2002 | EP1242057A2 Pharmacological inducement of the fed mode for enhanced drug administration to the stomach |
| 09/25/2002 | EP1242050A2 Survivin promotion of angiogenesis |
| 09/25/2002 | EP1242049A1 Hla class i a2 tumor associated antigen peptides and vaccine compositions |
| 09/25/2002 | EP1241945A2 Cancer immunotherapy and diagnosis using cytochrome p450 1b1 |
| 09/25/2002 | EP1159000B1 Preparation for the treatment of pigmentation disorders |
| 09/25/2002 | EP1146897B1 Use of a melanoma inhibiting activity factor (mia) for cartilage and bone repair |
| 09/25/2002 | EP1093359B1 Method for preparing fibrillin from cnidaria, and resulting compositions useful in cosmetics |
| 09/25/2002 | EP1061897B1 Glycylglycine oleamide in dermo-cosmetology |
| 09/25/2002 | EP1017413B1 Liquid interferon-beta formulations |
| 09/25/2002 | EP0981549B1 Use of an inhibitor substance for the improvement of neuronal regeneration |
| 09/25/2002 | EP0980263B1 Combined product associating a nucleic acid with a substance breaking up the extracellular matrix for gene therapy |
| 09/25/2002 | EP0972020B1 Insulin-like growth factor agonist molecules |
| 09/25/2002 | EP0960124A4 Serine substituted mutants of bcl-xl/bcl-2 associated cell death regulator |
| 09/25/2002 | EP0948345B1 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction |
| 09/25/2002 | EP0942745B1 Use of hyaluronidase |
| 09/25/2002 | EP0920329B1 Stabilization of interferons in aqueous solution by arabic gum |
| 09/25/2002 | EP0910398B1 Method of stimulating cilia |
| 09/25/2002 | EP0871656B1 Dolastatin derivatives, their preparation and use |
| 09/25/2002 | EP0806958A4 Inhibition of platelet binding |
| 09/25/2002 | EP0804591B1 Serum paraoxonase |
| 09/25/2002 | EP0696320B1 Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor |
| 09/25/2002 | EP0691850B1 Factor xiii for treatment of skin wounds |
| 09/25/2002 | CN1371424A Activatable recombinant neurotoxins |
| 09/25/2002 | CN1371421A Tankyrase 2 materials and methods |
| 09/25/2002 | CN1371416A Human CTLA-4 antibodies and their uses |
| 09/25/2002 | CN1371390A Human G-protein coupled receptor |
| 09/25/2002 | CN1371388A Hexapeptide with stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation differentiation and apoptosis |
| 09/25/2002 | CN1371371A Novel derivatives of flavones, xanthones and coumarins |
| 09/25/2002 | CN1371289A Gene therapy using TGF-beta |
| 09/25/2002 | CN1371288A Method for preparing polycation based bioconjugates suitable for transporting different kinds of active substances within the body |
| 09/25/2002 | CN1371286A Use of cyclooxygenase-2 inhibitor matrix metallappoteinase inhibitor antineoplastic agent and optionally radiation as combination treatment of neoplasia |
| 09/25/2002 | CN1371284A Multi-dose erythropoietin formulations |
| 09/25/2002 | CN1371243A Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 09/25/2002 | CN1370843A Functions of Tob gene in central nervous system of mammol and its application |
| 09/25/2002 | CN1370599A Anticancer capsule containing bioactive enzyme extracted from venom and its prepn |
| 09/25/2002 | CN1370598A Application of calcitonin relative gene polypeptide in treating beart failure and cardiovascular disease |
| 09/25/2002 | CN1370523A Salmon calcitonin snuff and its prepn |
| 09/24/2002 | US6455888 Memory cell structure for elimination of oxynitride (ONO) etch residue and polysilicon stringers |
| 09/24/2002 | US6455705 Distillation-free; chemical intermediates for the production of angiotensin-converting enzyme (ace) inhibitors |
| 09/24/2002 | US6455687 Human lactoferrin |
| 09/24/2002 | US6455686 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 09/24/2002 | US6455685 Detecting modulators of immune response; obtain nucleotide sequences, incubate with modulator, remove unbound modulator, detect bound complexes |
| 09/24/2002 | US6455683 Nucleotidesequences coding protein for use in the prevetion and treatment of infectious, inflammatory and allergic diseases |
| 09/24/2002 | US6455677 FAPα-specific antibody with improved producibility |
| 09/24/2002 | US6455676 Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging |